You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Ticagrelor for the treatment of acute coronary syndromes

  • Technology appraisal guidance
  • Reference number: TA236
  • Published:  26 October 2011
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Acute coronary syndromes - ticagrelor: consultee and commentator comments on the ACD

  • Acute coronary syndromes - ticagrelor: AstraZeneca

  • Acute coronary syndromes - ticagrelor: British Cardiovascular Society, British Cardiovascular Intervention Society and the Royal College of Physicians

  • Acute coronary syndromes - ticagrelor: British Heart Foundation

  • Acute coronary syndromes - ticagrelor: Royal College of Nursing

  • Acute coronary syndromes - ticagrelor: Department of Health

  • Acute coronary syndromes - ticagrelor: NHS Bradford and Airedale

  • Acute coronary syndromes - ticagrelor: NHS Oxfordshire

  • Acute coronary syndromes - ticagrelor: Daiichi Sankyo UK Ltd and Eli Lilly


This page was last updated: 14 September 2011

Back to top